Language switcher

This page has not been translated yet

Professor Dr Adriano Aguzzi

  • Section Pathology and Forensic Medicine
  • Location Zürich, Switzerland
  • Election year 2001

Research

Research Priorities: Neuropathology, prions, bovine spongiform encephalopathy (BSE), Creutzfeldt-Jakob disease, neurodegenerative diseases, Alzheimer’s
Adriano Aguzzi is an Italian-Swiss physician and neuropathologist. He investigates the molecular basis of prion diseases – rare progressive diseases such as bovine spongiform encephalopathy (BSE) and Creutzfeldt–Jakob disease. His work has identified the key steps in the pathogenesis of prion diseases. Adriano Aguzzi also studies the basic mechanisms that lead to the creation of neurodegenerative diseases and thus deepens our understanding of them.
Adriano Aguzzi specialised in neuroscience and immunology. His research combines transgenetics with molecular and immunological techniques. His work has identified the decisive steps in the pathogenesis of prion diseases, revealed the cells and molecules involved in prion neuroinvasion (prions being abnormally folded proteins), and elucidated the cellular mechanisms that lead to brain damage in the case of these diseases.
In addition, Adriano Aguzzi investigates the basic mechanisms of neurodegeneration and, in particular, the mechanisms that lead to the creation of neurodegenerative diseases such as Alzheimer’s and other forms of dementia. By combining fluorochrome chemistry and molecular genetics he develops 3D atlases of pathology and morphology of various cell types that are involved in brain neurodegeneration.
Another important aspect of his research concerns the interplay between the nervous system and the immune system in order to better understand how these systems cooperate and mutually influence each other. Adriano Aguzzi studies how protein aggregates, as they occur in Alzheimer’s and other diseases, arise in the brain and what role the immune system plays in this. He analyses the molecular mechanisms that lead to this aggregation and their effects on neuronal health.

  • 2004-2017 Co-Head, Department of Pathology, University Zurich Hospital (USZ), University of Zurich (UZH), Zurich, Switzerland
  • since 1998  Professor, Medical Faculty and Faculty of Natural Sciences, UZH, Zurich, Switzerland
  • since 1997  Professor and Director, Institute of Neuropathology, USZ, UZH, Zurich, Switzerland
  • since 1995  Director, Swiss National Reference Center for Prion Diseases (NRPE), USZ, UZH, Zurich, Switzerland
  • 1993-1997 Consultant and Lecturer, Pathology and Neuropathology, USZ, UZH, Zurich, Switzerland
  • 1989-1992  Postdoctoral Fellow, Research Institute of Molecular Pathology (IMP), Vienna, Austria
  • 1986-1989  Training as Physician for Neuropathology, USZ, UZH, Zurich, Switzerland
  • 1985  United States Medical Licensing Examination (USMLE), Educational Commission for Foreign Medical Graduates (ECFMG), Philadelphia, USA
  • 1983  Dissertation, Columbia University, New York City, USA
  • 1980-1986  Degree in Medicine, University of Freiburg, Freiburg, Germany, as well as University of Basel, Basel, Switzerland

  • since 2009 Member, Scientific Advisory Board, Instituto Italiano di Tecnologia (IIT), Genoa, Italy
  • since 2006 President, Foundation Board, Neuropath Foundation, Zurich, Switzerland
  • since 2005 Member, Scientific Advisory Board, Istituto di Ricerca in Biomedicina (IRB), Bellinzona, Switzerland
  • 2004-2008 Member, Advisory Board, Giovanni Armenise Harvard Foundation, Boston, USA
  • 2004-2005 Member, Wellcome Trust Neurosciences Committee, London, UK
  • 2003-2010 Director, Board, European Brain Research Institute Rita Levi-Montalcini (EBRI)
  • since 2003 Member, Advisory Board, Vienna Science and Technology Fund (WWTF), Vienna, Austria
  • 2003-2008 Member, Supervisory Board, Roche Research Foundation (RRF), F. Hoffmann-La Roche Ltd., Basel, Switzerland
  • 2003-2007 Member, Council, Eidgenössische Technische Hochschule (ETH) Zurich, Zurich, Switzerland
  • since 2002 Member, Advisory Board, Interdisciplinary Center for Neurosciences (IZN), University of Heidelberg, Heidelberg, Germany
  • 2002-2007 President, Scientific Council, Swiss Institute for Experimental Cancer Research (ISREC), Ecole polytechnique fédérale de Lausanne (EPFL), Switzerland
  • 2001-2009 Member, Centre for Molecular Biology (ZMBH), University of Heidelberg, Heidelberg, Germany
  • 2001-2006 Member, Advisory Board, Julius Klaus Foundation for Genetics and Social Anthropology, Zurich, Switzerland
  • since 2000 Member, Advisory Board, European Mouse Mutant Archive (EMMA)
  • 2000-2001 Member, Swiss Federal Committee for Biosafety (SECB), Switzerland
  • 1999-2007 Member, Board of Directors, International Society of NeuroVirology (ISNV), USA
  • 1999-2002 Member, Prions Study Group, International Committee on Taxonomy of Viruses (ICTV)
  • 1998-2002 President, Swiss Society of Neuropathology (SSNPAth), Switzerland
  • 1998-2008 Member, Advisory Board, Charles-Rodolphe Brupbacher Foundation, Vaduz, Liechtenstein
  • 1997-2004 Member, Spongiform Encephalopathy Advisory Committee (SEAC), Government, UK
  • 1997-2001 Member, Board of Referees, Human Frontiers Science Program (HFSP), Strasbourg, France
  • 1997-2002 Member, TSE/BSE ad hoc Group, European Commission (EC)
  • 1997-1999 Member, Advisory Board, International Society of Neuropathology, UK
  •  Member, Board of Reviewing Editors (BoRE), Science
  •  Member, Editorial Board, Brain Pathology
  •  Member, Editorial Board, Nature
  •  Member, Editorial Board, Nature Medicine
  •  Member, Editorial Board, The Lancet
  •  Member, Editorial Board, Journal of Neuroscience
  •  Editor-in-Chief, Swiss Medical Weekly
  • Honorary Member, Società Italiana di Virologia – Italian Society for Virology (SIV-ISV)
  • Member, Association “Forschung für Leben”, Zurich, Switzerland
  • Member, German Society of Neuropathology and Neuroanatomy (DGNN), Germany

  • 2024-2027 Principal Investigator, Project “Genetic modifiers and actionable molecular targets against synucleinopathies”, Swiss National Science Foundation (SNF), Switzerland
  • 2022-2026 Principal Investigator, Project “Modifiers and cofactors of prion replication, toxicity and tropism”, SNF, Switzerland
  • 2021-2023 Principal Investigator, Project “Understanding the Heterogeneity of the SARS-CoV-2 Immune Response”, NOMIS Foundation, Zurich, Switzerland
  • 2019-2023 Principal Investigator “Exploring the Locales of Cognitive Decline: Cellular and Molecular 3D Atlases of Brain Pathology in Aging and in Neurodegeneration”, NOMIS Foundation, Zurich, Switzerland
  • 2019-2023 Co-Principal Investigator, Project “PrP and its receptor GPR126: guardians of axomyelinic integrity and druggable targets against demyelinating diseases”, SNF, Switzerland
  • 2016-2019 Principal Investigator, Project “REFRAME – Pathway complexities of protein misfolding in neurodegenerative diseases: a novel approach to risks evaluation and model development”, SNF, Switzerland
  • 2015-2020 Principal Investigator, Advanced Grant “Neuroprotective human antibodies to the flexible tail of the prion protein”, Horizon 2020, European Research Council (ERC)
  • 2015-2018 Principal Investigator, Project “Systems Biology of Prion diseases”, Swiss Initiative in Systems Biology (SystemsX.ch), Switzerland
  • 2015-2018 Principal Investigator, Project “Immunotherapy of familial prion diseases”, SNF, Switzerland
  • 2012-2022 Principal Investigator, Project “The prion protein in health and disease”, SNF, Switzerland
  • 2007-2011 Participating Scientist, Project “Pathophysiology of prion accumulation in skeletal muscle”, DFG, Germany
  • 1996-2000 Co-Principal Investigator, Project “Mechanisms of prion replication and spread within an infected organism”, SNF, Switzerland

  • 2017 InBev-Baillet Latour Health Prize, InBev Baillet-Latour Foundation, Leuven, Belgium
  • 2013 Hartwig Piepenbrock-DZNE Prize, German Center for Neurodegenerative Diseases (DZNE), Germany
  • 2012 Théodore Ott Prize, Swiss Academy of Medical Sciences (SAMW), Switzerland
  • 2009 Antonio Feltrinelli Award, Accademia Nazionale dei Lincei, Rome, Italy
  • 2005 Ernst A.H. Friedheim Memorial Lecture, Rockefeller University, New York City, USA
  • 2005 Honorary Doctorate, University of Teramo, Teramo, Italy
  • 2004 Swiss Science Prize Marcel Benoist, Marcel Benoist Foundation, Bern, Switzerland
  • 2004 Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, Hamdan Bin Rashid Al Maktoum Foundation for Medical and Education Sciences, Dubai, United Arab Emirates
  • 2004 Glaxo Award for Translational Neuroscience, GlaxoSmithKline Foundation Munich, Munich, Germany
  • 2003 Robert Koch Award, Robert Koch Foundation, Berlin, Germany
  • 2002 Honorary Doctorate, University of Liège (ULiège), Liège, Belgium
  • 2002 Honorary Doctorate, University of Bologna, Bologna, Italy
  • 2002 Member, Royal College of Physicians (RCP), UK
  • 2001 Leopoldina Research Award, German National Academy of Sciences Leopoldina, Germany
  • 2001 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Award and Lecture, National AIDS Treatment Advocacy Project (NATAP), USA
  • 2001 Member, Austrian Academy of Sciences (ÖAW), Austria
  • since 2001 Member, German National Academy of Sciences Leopoldina, Germany
  • 2000 Aschoff Medal, University of Freiburg, Freiburg, Germany
  • 2000 Cameron Lecturer, University of Birmingham, Birmingham, UK
  • 2000 Biotech Award, Milan, Italy
  • 2000 Member, Swiss Academy of Engineering Sciences (SAMW), Switzerland
  • 1999 Ernst Jung Prize for Medicine, Jung Foundation for Science and Research, Hamburg, Germany
  • 1999 Tibor Greenwalt Memorial Award and Lectureship, Association for the Advancement of Blood and Biotherapies (AABB), San Francisco, USA
  • 1998 Gold Medal, European Molecular Biology Organization (EMBO), Heidelberg, Germany
  • since 1998 Member, EMBO, Heidelberg, Germany
  • 1998 Cloëtta Prize, Professor Dr Max Cloëtta Foundation, Zurich, Switzerland
  • 1997 Pfizer Award for Neurobiology, Pfizer AG, Zurich, Switzerland
  • since 1996 Member, Fellowship Examination, Royal College of Pathologists (FRCPath), London, UK
  • 1995 Ernst Th. Jucker Prize, Dr Ernst Th. Jucker Foundation, Zurich, Switzerland

The Leopoldina uses cookies

We use cookies on our website. Some of them are necessary (functional cookies), while others are not necessary but help us to improve our online offering and operate it economically.

You can consent to the use of non-essential cookies by clicking on the "Accept all" button or by clicking on individual settings and agreeing to them by clicking on "Accept selection".

You can access these settings at any time and deselect cookies at a later date.

Functional

These cookies are technically necessary in order to provide the following core functionalities of the website:

  • Display of the website
  • Anonymisation of IP addresses within log files
  • Status cookie consent
Comfort

In addition to necessary cookies, we also use cookies to make your use of the website more pleasant. If you accept these cookies, external media will be loaded without your further consent.

Tracking

With the help of statistics cookies, we can better customise the content and services of our website to your interests and needs. For statistics and analyses, we use the product Matomo for statistics and analyses.

External link warning

Die Nutzung dieses Teildienstes erfordert ihre Einwilligung in die Verarbeitung zusätzlicher personenbezogener Daten durch einen selbständigen Verantwortlichen: Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gelten folgende Datenschutzhinweise: https://matterport.com/de/node/44. Mit der Einwilligung durch Klick auf „Ok“ kann auch eine Übermittlung von personenbezogenen Daten in ein Land außerhalb der Europäischen Union erfolgen. Die Einwilligung ist freiwillig. Eine Ablehnung führt zu keinen Nachteilen. Eine erteilte Einwilligung kann jederzeit mit Wirkung für die Zukunft widerrufen werden.

Ich bin damit einverstanden, dass bei Nutzung dieses Teildienstes zusätzliche personenbezogene Daten verarbeitet werden. Dabei verarbeitete Datenkategorien: technische Verbindungsdaten des Serverzugriffs (IP-Adresse, Datum, Uhrzeit, abgefragte Seite, Browser-Informationen), Daten zur Erstellung von Nutzungsstatistiken und Daten über die Nutzung der Website sowie die Protokollierung von Klicks auf einzelne Elemente. Zweck der Verarbeitung: Auslieferung von Inhalten, die von Dritten bereitgestellt werden. Rechtsgrundlage für die Verarbeitung: Ihre Einwilligung nach Art. 6 (1) a DSGVO, Art. 49 DSGVO. Verantwortlicher für die Datenverarbeitung Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gilt die Datenschutzerklärung von Matterport Inc.: https://matterport.com/de/node/44.

Visit page ▸